Online citations, reference lists, and bibliographies.
← Back to Search

Human Immunodeficiency Virus Infection Modifies The Natural History Of Chronic Parenterally-acquired Hepatitis C With An Unusually Rapid Progression To Cirrhosis.

B. Soto, A. Sánchez-Quijano, L. Rodrigo, J. D. del Olmo, M. García-Bengoechea, J. Hernández‐Quero, C. Rey, M. A. Abad, M. Rodríguez, M. Sales Gilabert, F. Gonzalez, P. Miron, A. Caruz, F. Relimpio, R. Torronteras, M. Leal, E. Lissen
Published 1997 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND/AIMS To investigate the possible role of HIV infection in the natural history of chronic parenterally-acquired hepatitis C. METHODS A multicenter cross-sectional study was performed in 547 patients with chronic parenterally-acquired hepatitis C with or without HIV infection (116 HIV-positive and 431 HIV-negative). Approximate duration of HCV infection was estimated in all patients included, and histologic diagnoses made at different time intervals following HCV infection were analyzed in both groups. Factors related to serum HCV-RNA levels were also investigated. RESULTS Histologic findings were similar in liver biopsies from both HIV-infected and noninfected patients. However, in the first 10 years, 13 out of 87 (14.9%) HIV-positive subjects developed cirrhosis, in comparison with 7 out of 272 (2.6%) in the HIV-negative group (p < 0.01). Similar results were found in the first 5 and 15 years, respectively, and most of the HIV-negative patients with cirrhosis (42 out of 56) developed cirrhosis in a time interval longer than 15 years. Consequently, mean interval from estimated time of HCV infection to cirrhosis was significantly longer in HIV-negative than HIV-positive patients (23.2 vs. 6.9 years; p < 0.001). Chronic active hepatitis (with and without cirrhosis) and long duration of HCV infection were significantly associated with higher HCV load (p < 0.05). Finally, HIV-positive patients with CD4+ cell counts > 500 cells/ml showed a lower HCV load than those with < 500 cells/ml (p < 0.05). CONCLUSIONS HIV infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. HIV-related immunodeficiency may be a determinant of higher hepatitis C viremia levels and more severe liver damage.
This paper references
The epidemiology of viral hepatitis in the United States.
Alter Mj (1994)
10.1128/JCM.31.10.2679-2682.1993
Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections.
K. Sherman (1993)
10.1002/HEP.1840170404
Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease
H. Hagiwara (1993)
10.1016/S0163-4453(94)94440-7
High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in Spain.
V. Soriano (1994)
10.1002/HEP.1840180609
The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. Intravenous drug use
S. Gordon (1993)
10.1056/NEJM199412153312402
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
K. Bjøro (1994)
10.1016/0016-5085(94)90759-5
Quantitation of hepatitis C virus RNA in liver transplant recipients
O. Chazouilleres (1994)
10.1056/NEJM199212313272702
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.
M. Alter (1992)
Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.
M. Eyster (1993)
10.1002/HEP.1840180502
Hepatitis C virus infection in kidney transplant recipients
J. Lau (1993)
10.1093/INFDIS/166.2.424
Hepatitis C virus replication during acute infection in the chimpanzee.
M. Shindo (1992)
10.1016/S0168-8278(96)80182-6
Histopathology of chronic hepatitis C in relation to epidemiological factors.
J. Delladetsima (1996)
10.1056/NEJM199212313272703
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
L. Seeff (1992)
10.1182/BLOOD.V84.4.1020.BLOODJOURNAL8441020
Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study.
M. Eyster (1994)
10.1136/jcp.47.11.965
Virus infections in primary immunodeficiency.
A. Webster (1994)
10.1097/00002030-199510000-00003
High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV
B. Cribier (1995)
10.1002/HEP.1840180104
Quantification of hepatitis C virus by competitive reverse transcription—polymerase chain reaction: Increase of the virus in advanced liver disease
N. Kato (1993)
[Hepatitis in drug addicts].
M. Bruguera (1984)
10.1093/CLINIDS/17.1.117
Hepatitis C virus infection in patients infected with the human immunodeficiency virus.
C. Quan (1993)



This paper is referenced by
Experiencia argentina con pacientes positivos para el virus de la inmunodeficiencia humana en lista de espera para trasplante hepático: Análisis preliminar
A. Villamil (2013)
10.7326/0003-4819-158-2-201301150-00574
Screening for Hepatitis C Virus Infection in Adults: A Systematic Review for the U.S. Preventive Services Task Force
R. Chou (2013)
10.1111/j.1365-2893.2010.01293.x
Stronger hepatitis C virus‐specific CD8+ T‐cell responses in HIV coinfection
Lisa P. Barrett (2011)
10.1182/BLOOD.V100.5.1584.H81702001584_1584_1589
End-stage liver disease in persons with hemophilia and transfusion-associated infections.
J. Goedert (2002)
Evaluating T-cell Immunity in HCV/HIV Co-infection
Bahareh Vali (2011)
10.1590/s1413-86702006000100004
Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV.
E. Braga (2006)
Modeling HCV infection, immunopathogenesis, and therapy in humanized mice
Michael L Washburn (2010)
ASSESSING THE IMPACT OF ANTIRETROVIRAL TREATMENT INTERRUPTION ON PROGRESSION OF LIVER FIBROSIS IN ADULTS CO-INFECTED WITH HIV AND HEPATITIS C
Julia Thorpe (2010)
10.1177/003693300004500201
Are Cirrhosis and its Complications Inevitable in Hepatitis C Virus Infection?
T. Delahooke (2000)
10.1111/j.1365-2893.2007.00962.x
Liver fibrosis on account of chronic hepatitis C is more severe in HIV‐positive than HIV‐negative patients despite antiretroviral therapy
V. de Lédinghen (2008)
10.1002/HEP.1840360707
Fibrosis and disease progression in hepatitis C
P. Marcellin (2002)
10.1086/506440
Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
M. Sánchez-Conde (2006)
10.1086/587843
Impact of HIV on host-virus interactions during early hepatitis C virus infection.
M. Danta (2008)
10.1097/00004836-200111000-00005
Hepatitis C and Human Immunodeficiency Virus Coinfections
M. Dodig (2001)
10.1590/S0102-35862001000100009
Sndrome hepatopulmonar em paciente com cirrose por vrus C e SIDA
M. A. Ferreira (2001)
10.1007/S11901-005-0028-Y
The influence of hiv coinfection on the natural history of hcv infection
Arun Swaminath (2005)
10.1086/321909
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.
C. Graham (2001)
10.3109/00365548.2013.879994
Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy—Factors associated with advanced fibrosis
Anna Jerkeman (2014)
10.1136/gut.51.4.601
Hepatitis C and HIV-1 coinfection
A. Mohsen (2002)
10.1016/j.bbalip.2010.04.008
Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus X protein in zebrafish.
Yun Sheng Shieh (2010)
10.1089/08892220152596614
γδ T cell activation by chronic HIV infection may contribute to intrahepatic Vδ1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy
C. Agrati (2001)
10.1080/003655201750305530
TT virus infection in patients with primary hypogammaglobulinaemia: natural history and relationship to liver disease in the immunocompromised host.
K. Bjøro (2001)
10.1007/S12157-008-0059-4
Prévalence des anticorps antivirus de l’hépatite C chez des patients porteurs de sida sous traitement à Cotonou
J. Séhonou (2008)
10.1093/jac/dkp070
Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.
J. Moltó (2009)
10.1007/978-3-642-57075-9_3
Hepatocyte Apoptosis Triggered by Natural Substances (Cytokines, Other Endogenous Molecules and Foreign Toxins)
D. Pessayre (2000)
Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
S. Cinti (2008)
10.1157/13094351
Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario
P. S. D. L. Hoya-Zamácola (2006)
10.1007/s15010-013-0502-3
Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection
C. Sagnelli (2013)
10.1007/978-1-4419-1712-6_4
Pathology of HIV-Associated Liver Disease
A. Noffsinger (2012)
10.1186/s12879-015-0920-1
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection
A. Hodowanec (2015)
10.1016/J.CLD.2005.05.008
Treatment of hepatitis C virus/HIV coinfection.
Sooyun Chun (2005)
10.1086/318501
Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.
I Bica (2001)
See more
Semantic Scholar Logo Some data provided by SemanticScholar